17 April 2020

• US National Institutes of Health launches Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), a public-private partnership to expedite and coordinate development of COVID-19 treatment and vaccines. Source
• Sinovac launches phase I/II trial of its COVID-19 vaccine candidate, CoronaVac. Source

Return to the timeline